Overlap of asthma and chronic obstructive pulmonary disease

Purpose of review Asthma and chronic obstructive pulmonary disease (COPD) are both defined by the presence of airflow obstruction, but they present distinguishing differences in terms of both risk factors and clinical phenotypes. Yet it is quite common in the clinical setting to observe patients with asthma showing COPD-like phenotypes, and vice versa, making it a priority to search for optimal prevention, treatment, and management strategies for these cases of coexisting lung obstructive diseases. Recent findings Recent studies have provided further evidence of strong epidemiologic and clinical links between asthma and COPD. Adult subjects with active asthma are as much as 12 times more likely to acquire COPD over time than subjects with no active asthma. Signs identifying patients with asthma predisposed to developing COPD may already be present at the early stages of the disease, a finding with potential implications for prevention of COPD. In addition to spirometry and other pulmonary function tests (such as measurements of residual volume and diffusing capacity of the lung for carbon monoxide), recent evidence suggests that the assessment of type and degree of airway remodeling and the evaluation of inflammatory markers might prove useful in the future to characterize phenotypically patients with coexisting asthma and COPD. Summary The nature of the association between asthma and COPD remains unclear and open to discussion. Further research is required to develop effective management algorithms for patients with multiple obstructive lung diseases, determine to what extent early treatment and optimal management of asthma may protect against progression into COPD, and identify genetic markers of individual susceptibility to specific lung disease phenotypes and pharmacologic treatments.

[1]  Jan Stolk,et al.  Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[2]  Stefano Guerra,et al.  Asthma as a risk factor for COPD in a longitudinal study. , 2004, Chest.

[3]  S. Guerra,et al.  Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. , 2004, American journal of respiratory and critical care medicine.

[4]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[5]  J. Yoshikawa,et al.  Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. , 2004, The American journal of medicine.

[6]  P. Chanez,et al.  Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? , 2004, Thorax.

[7]  P. Kuna,et al.  Long-Term Deterioration of Lung Function in Asthmatic Outpatients , 2004, Respiration.

[8]  D. Postma,et al.  Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  R. Pellegrino,et al.  Assessment of emphysema in COPD: a functional and radiologic study. , 2004, Chest.

[10]  M. Decramer,et al.  Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. , 2004, Chest.

[11]  D. Postma,et al.  The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation , 2004, European Respiratory Journal.

[12]  K. Beck,et al.  Clinical significance of elevated diffusing capacity. , 2004, Chest.

[13]  M. Tanimoto,et al.  Influence of long‐term cigarette smoking on immunoglobulin E‐mediated allergy, pulmonary function, and high‐resolution computed tomography lung densitometry in elderly patients with asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  S. Kawakami,et al.  Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma , 2003, European Respiratory Journal.

[15]  D. Johns,et al.  Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease , 2003, Internal medicine journal.

[16]  E. R. Sutherland,et al.  Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. , 2003, The Journal of allergy and clinical immunology.

[17]  Phil A. Silva,et al.  A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. , 2003, The New England journal of medicine.

[18]  R. Pauwels,et al.  Chronic obstructive pulmonary disease: molecular and cellularmechanisms , 2003, European Respiratory Journal.

[19]  R. Hubbard,et al.  Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey , 2003, BMJ : British Medical Journal.

[20]  G. Viegi,et al.  Chronic cough and phlegm in young adults , 2003, European Respiratory Journal.

[21]  Andrew J Wardlaw,et al.  Associations Between Polymorphisms of the High‐Affinity Immunoglobulin E Receptor and Late‐Onset Airflow Obstruction in Older Populations , 2003, Journal of the American Geriatrics Society.

[22]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[23]  E. Vartiainen,et al.  Smoking and atopy as determinants of sputum eosinophilia and bronchial hyper-responsiveness in adults with normal lung function. , 2003, Respiratory medicine.

[24]  Joan B Soriano,et al.  The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.

[25]  S. Spencer,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[26]  P. Macklem,et al.  Airway wall remodeling: friend or foe? , 2003, Journal of applied physiology.

[27]  F. Ram,et al.  Regular inhaled short acting β2 agonists for the management of stable chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis , 2003, Thorax.

[28]  J. Lötvall,et al.  Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation. , 2003, Respiratory medicine.

[29]  L. Boulet,et al.  Airway inflammation in asthma with incomplete reversibility of airflow obstruction. , 2003, Respiratory medicine.

[30]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[31]  G. O'Connor,et al.  Serum interferon-γ is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study , 2003 .

[32]  D. Postma,et al.  Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. , 2003, Thorax.

[33]  A. Buist,et al.  Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. , 2003, Chest.

[34]  Kathleen Kreiss,et al.  American Thoracic Society Statement: Occupational contribution to the burden of airway disease. , 2003, American journal of respiratory and critical care medicine.

[35]  L. Fabbri,et al.  Predominant emphysema phenotype in chronic obstructive pulmonary disease patients , 2003, European Respiratory Journal.

[36]  J. Carlin,et al.  Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42 , 2003, BMJ : British Medical Journal.

[37]  Tadashi Yokoi,et al.  Complexity of terminal airspace geometry assessed by computed tomography in asthma. , 2003, American journal of respiratory and critical care medicine.

[38]  L. Corbetta,et al.  Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[39]  S. Holgate,et al.  Airway remodeling in asthma: new insights. , 2003, The Journal of allergy and clinical immunology.

[40]  D. Postma,et al.  Airway remodeling and long-term decline in lung function in asthma , 2003, Current opinion in pulmonary medicine.

[41]  S. Guerra,et al.  The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics , 2003, European Respiratory Journal.

[42]  A. Buist,et al.  Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes , 2003, European Respiratory Journal.

[43]  L. Fabbri,et al.  Predominant emphysema phenotype in chronic obstructive pulmonary. , 2003, The European respiratory journal.

[44]  G. O'Connor,et al.  Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[45]  G. Trakada,et al.  Can High Resolution Computed Tomography Predict Lung Function in Patients with Chronic Obstructive Pulmonary Disease? , 2003, Lung.

[46]  D. Mahler The effect of inhaled β2-agonists on clinical outcomes in chronic obstructive pulmonary disease , 2002 .

[47]  M. Abramson,et al.  Prevalence of respiratory symptoms related to chronic obstructive pulmonary disease and asthma among middle aged and older adults , 2002, Respirology.

[48]  M. Tsukino,et al.  Longitudinal changes in airflow limitation and airway hyperresponsiveness in patients with stable asthma. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[49]  J. Bousquet,et al.  Eosinophilic inflammation in sputum of poorly controlled asthmatics , 2002, European Respiratory Journal.

[50]  G. Bonsignore,et al.  Lung function decline in bronchial asthma. , 2002, Chest.

[51]  P. Paré,et al.  Quantitative assessment of airway remodeling using high-resolution CT. , 2002, Chest.

[52]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[53]  T. Płusa,et al.  Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma. , 2002, Mediators of inflammation.

[54]  K. J. Macleod,et al.  High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity , 2002, Thorax.

[55]  P. Jeffery Remodeling in asthma and chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[56]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[57]  H Itoh,et al.  Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. , 2000, American journal of respiratory and critical care medicine.

[58]  P. Paré,et al.  Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. , 2000, American journal of respiratory and critical care medicine.

[59]  N. Orie,et al.  The dutch hypothesis , 2000, Chest.

[60]  J. Elias,et al.  Airway remodeling in asthma. Unanswered questions. , 2000, American journal of respiratory and critical care medicine.

[61]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[62]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[63]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[64]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[65]  D. Postma,et al.  The Dutch hypothesis (chronic non-specific lung disease) revisited. , 1991, The European respiratory journal.

[66]  M. Lebowitz,et al.  The relationship of childhood respiratory illness to adult obstructive airway disease. , 2015, The American review of respiratory disease.

[67]  M. Lebowitz,et al.  Quantitative relationships between cigarette smoking and ventilatory function. , 1977, The American review of respiratory disease.